Efficiency of biofilm removal by combination of water jet and cold plasma: an in-vitro study.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
06 05 2022
Historique:
received: 10 03 2022
accepted: 25 04 2022
entrez: 7 5 2022
pubmed: 8 5 2022
medline: 11 5 2022
Statut: epublish

Résumé

Peri-implantitis therapy is a major problem in implantology. Because of challenging rough implant surface and implant geometry, microorganisms can hide and survive in implant microstructures and impede debridement. We developed a new water jet (WJ) device and a new cold atmospheric pressure plasma (CAP) device to overcome these problems and investigated aspects of efficacy in vitro and safety with the aim to create the prerequisites for a clinical pilot study with these medical devices. We compared the efficiency of a single treatment with a WJ or curette and cotton swab (CC) without or with adjunctive use of CAP (WJ + CAP, CC + CAP) to remove biofilm in vitro from rough titanium discs. Treatment efficacy was evaluated by measuring turbidity up to 72 h for bacterial re-growth or spreading of osteoblast-like cells (MG-63) after 5 days with scanning electron microscopy. With respect to application safety, the WJ and CAP instruments were examined according to basic regulations for medical devices. After 96 h of incubation all WJ and CC treated disks were turbid but 67% of WJ + CAP and 46% CC + CAP treated specimens were still clear. The increase in turbidity after WJ treatment was delayed by about 20 h compared to CC treatment. In combination with CAP the cell coverage significantly increased to 82% (WJ + CAP) or 72% (CC + CAP), compared to single treatment 11% (WJ) or 10% (CC). The newly developed water jet device effectively removes biofilm from rough titanium surfaces in vitro and, in combination with the new CAP device, biologically acceptable surfaces allow osteoblasts to grow. WJ in combination with CAP leads to cleaner surfaces than the usage of curette and cotton swabs with or without subsequent plasma treatment. Our next step will be a clinical pilot study with these new devices to assess the clinical healing process.

Sections du résumé

BACKGROUND
Peri-implantitis therapy is a major problem in implantology. Because of challenging rough implant surface and implant geometry, microorganisms can hide and survive in implant microstructures and impede debridement. We developed a new water jet (WJ) device and a new cold atmospheric pressure plasma (CAP) device to overcome these problems and investigated aspects of efficacy in vitro and safety with the aim to create the prerequisites for a clinical pilot study with these medical devices.
METHODS
We compared the efficiency of a single treatment with a WJ or curette and cotton swab (CC) without or with adjunctive use of CAP (WJ + CAP, CC + CAP) to remove biofilm in vitro from rough titanium discs. Treatment efficacy was evaluated by measuring turbidity up to 72 h for bacterial re-growth or spreading of osteoblast-like cells (MG-63) after 5 days with scanning electron microscopy. With respect to application safety, the WJ and CAP instruments were examined according to basic regulations for medical devices.
RESULTS
After 96 h of incubation all WJ and CC treated disks were turbid but 67% of WJ + CAP and 46% CC + CAP treated specimens were still clear. The increase in turbidity after WJ treatment was delayed by about 20 h compared to CC treatment. In combination with CAP the cell coverage significantly increased to 82% (WJ + CAP) or 72% (CC + CAP), compared to single treatment 11% (WJ) or 10% (CC).
CONCLUSION
The newly developed water jet device effectively removes biofilm from rough titanium surfaces in vitro and, in combination with the new CAP device, biologically acceptable surfaces allow osteoblasts to grow. WJ in combination with CAP leads to cleaner surfaces than the usage of curette and cotton swabs with or without subsequent plasma treatment. Our next step will be a clinical pilot study with these new devices to assess the clinical healing process.

Identifiants

pubmed: 35524324
doi: 10.1186/s12903-022-02195-1
pii: 10.1186/s12903-022-02195-1
pmc: PMC9074283
doi:

Substances chimiques

Dental Implants 0
Plasma Gases 0
Water 059QF0KO0R
Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

157

Informations de copyright

© 2022. The Author(s).

Références

J Biomed Mater Res B Appl Biomater. 2014 Aug;102(6):1289-96
pubmed: 24449377
Clin Oral Implants Res. 2020 Nov;31(11):1072-1077
pubmed: 32870513
PLoS One. 2012;7(8):e42539
pubmed: 22880025
J Periodontol. 2014 Nov;85(11):e363-9
pubmed: 25060742
Maxillofac Plast Reconstr Surg. 2018 May 13;40(1):12
pubmed: 29774206
Am J Surg. 1972 Sep;124(3):373-7
pubmed: 5056898
Periodontol 2000. 2010 Jun;53:167-81
pubmed: 20403112
Ann Surg. 1978 Feb;187(2):170-3
pubmed: 343735
Clin Oral Implants Res. 2013 Aug;24(8):904-9
pubmed: 22626061
Arch Oral Biol. 2012 Jul;57(7):940-7
pubmed: 22365324
Clin Oral Implants Res. 2015 Aug;26(8):931-936
pubmed: 24734854
Br Dent J. 2014 Oct;217(7):345-349
pubmed: 25303581
Springerplus. 2016 Feb 01;5:105
pubmed: 26877903
J Dent Res. 2016 Jan;95(1):50-7
pubmed: 26285807
Mil Med. 1998 Dec;163(12):844-6
pubmed: 9866365
PLoS One. 2011;6(10):e25893
pubmed: 22016784
J Biomed Mater Res B Appl Biomater. 2022 May;110(5):1044-1055
pubmed: 34897974
Clin Oral Implants Res. 2018 Apr;29(4):404-410
pubmed: 29575025
Implant Dent. 2017 Dec;26(6):904-910
pubmed: 29120888
Biomaterials. 2015 Jun;52:327-34
pubmed: 25818439
Nanomaterials (Basel). 2020 Jul 31;10(8):
pubmed: 32751895
Biology (Basel). 2020 Jan 13;9(1):
pubmed: 31940979
J Biomed Mater Res A. 2012 Jul;100(7):1901-6
pubmed: 22492543
J Clin Periodontol. 2017 Jun;44(6):672-680
pubmed: 28303583
BMC Oral Health. 2021 Jun 4;21(1):286
pubmed: 34088301
BMC Oral Health. 2017 Nov 28;17(1):137
pubmed: 29183313
Aust Dent J. 2017 Dec;62(4):510-515
pubmed: 28590506
J Dent Res. 2016 Jan;95(1):43-9
pubmed: 26701919
Clin Oral Investig. 2021 Dec;25(12):6633-6642
pubmed: 33893556
Clin Oral Implants Res. 2016 Oct;27(10):1233-1242
pubmed: 26864128
J Periodontol. 2016 Jul;87(7):809-19
pubmed: 26923474
J Clin Periodontol. 2017 Dec;44(12):1285-1293
pubmed: 28836279
J Periodontol. 2021 Apr;92(4):580-591
pubmed: 32846000
Clin Oral Implants Res. 2014 Jul;25(7):838-42
pubmed: 23551490
Biology (Basel). 2021 Aug 13;10(8):
pubmed: 34440005
J Periodontol. 2013 Apr;84(4):436-43
pubmed: 23537178
Clin Oral Implants Res. 2011 Apr;22(4):349-56
pubmed: 21561476
J Biomed Mater Res B Appl Biomater. 2009 Jan;88(1):83-91
pubmed: 18615487
Clin Oral Implants Res. 2015 Mar;26(3):314-9
pubmed: 24373056
Implant Dent. 2015 Jun;24(3):307-16
pubmed: 25734943
Clin Oral Implants Res. 2013 Jun;24(6):666-70
pubmed: 22409152
J Clin Periodontol. 2012 Apr;39(4):400-7
pubmed: 22324415
Eur J Oral Implantol. 2012;5 Suppl:S71-81
pubmed: 22834396

Auteurs

Rutger Matthes (R)

Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Fleischmannstr. 42, 17475, Greifswald, Germany.

Lukasz Jablonowski (L)

Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Fleischmannstr. 42, 17475, Greifswald, Germany.

Vinay Pitchika (V)

Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Fleischmannstr. 42, 17475, Greifswald, Germany.

Birte Holtfreter (B)

Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Fleischmannstr. 42, 17475, Greifswald, Germany.

Christian Eberhard (C)

Sirona Dental Systems GmbH, Bensheim, Germany.

Leo Seifert (L)

Sirona Dental Systems GmbH, Bensheim, Germany.

Torsten Gerling (T)

ZIK Plasmatis, Leibniz-Institute for Plasma Science and Technology e.V. (INP), Greifswald, Germany.

Laura Vilardell Scholten (L)

ZIK Plasmatis, Leibniz-Institute for Plasma Science and Technology e.V. (INP), Greifswald, Germany.

Rabea Schlüter (R)

Imaging Center of the Department of Biology, University of Greifswald, Greifswald, Germany.

Thomas Kocher (T)

Department of Restorative Dentistry, Periodontology, Endodontology, Preventive Dentistry and Pedodontics, Dental School, University Medicine Greifswald, Fleischmannstr. 42, 17475, Greifswald, Germany. kocher@uni-greifswald.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH